newsfilter
← Latest News
GlobeNewswire·

BioCryst Reports Third Quarter 2026 Financial Results

— Total net revenue of $180.3 million and ORLADEYO® net revenue of $174.8 million — — Operating profit of $53.3 million and Non-GAAP operating profit of $86.5 million — — Maintained Full Year 2026 ORLADEYO revenue